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Teratological Research Using In Vitro
Systems. IV. Cells in Culture
by John J. Welsh*
Several in vitro cellular systems designed to screen agents for teratogenic potential are described in this
report. These assays were selected from a review of literature published through the spring of 1986 that
generated over 100 references on teratological research using cell-based systems. Some ofthe assays have
abroaderapplication than others, but mostrequire confirmation by one ormore additionalcomplementary
tests because of the specificity of the teratogenic mechanism the assays are investigating. Included are
systems that use analysis of tumor cell attachment; intercellular communication; growth of human em-
bryonic palatal mesenchyme cells; progesterone production in porcine granulosa cells; differentiation of
embryonic neural crest, limb bud, midbrain, and Drosophila cells; and differentiation of tumor cells.
Because ofthe dynamic nature of cell culture work, the group of assays listed here should not be viewed
as encompassing all cell systems ofvalue with regard to teratogenicity testing; instead, the list represents
several of the more prominent systems now being evaluated by the scientific community.
Inhibition of Tumor Cell Attachment
to Concanavalin A-Coated Surfaces
Introduction
Interactions between embryonic cells have long
been thought to be critical factors in embryonic de-
velopment. The breakdown ofthese intracellular com-
munications by physical intervention or genetic de-
fects are thought to be associated with developmental
anomalies. Braun and associates (1) have described an
in vitro cell-to-surface recognition system using
mouse ascites tumor cells to screen for potential ter-
atogens. The use of tumor cells in this type of assay
has several advantages: tumor cells are readily avail-
able, homogeneous, easy to prepare, and share many
characteristics with embryonic cells. One character-
istic that transformed fibroblasts, tumor cells, and
some embryonic cells share is the ability to attach
themselves to lectin-coated plastic surfaces, whereas
normal fibroblasts attach poorly. This difference has
been exploited as a means ofdifferentiating chemicals
that alter cell-surface interactions from those that do
not. Tumor cells have been shown to attach rapidly
and irreversibly to lectin-coated plastic disks because
ofinteractions between carbohydrate moieties on the
cell membrane and lectin receptors on the plastic sur-
face. Requirements include metabolic energy and an
intact cell surface. Attachment can be quantitated by
the use ofradiolabeled cells. Braun and Horowicz (2)
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have proposed that any agent capable of interfering
with lectin-mediated attachment can be expected to
interferewithmorphogenicrecognitionprocesses and
lead to congenital malformations.
Methodology
This assay entails inoculating mice with ascitic
mouse ovarian tumor cells 1 week before the assay is
performed. The cells are radioactively labeled by in-
traperitoneal injection with tritiated thymidine about
12 hrbefore use. Cells are then harvested and allowed
toincubate at37°C for30mininaPetridishcontaining
the test compound in solution. Since attachment is
dependent upon pH, the test solution is titrated to 7.4
before exposure to the cells. Several polyethylene
disks coated with concanavalin A are placed in the
suspension for 20 min at room temperature, then re-
moved, washed in saline, and counted in Aquasol
(New England Nuclear, Boston, MA) with a liquid
scintillation counter. A set of eight or nine concen-
trations is used for each compound tested. Concen-
trations are maintained below overtly toxic levels, as
determined by trypan blue exclusion. Braun has sug-
gested that in the event cytotoxicity is noted, incu-
bation with 5% fetal calf serum (FCS) should be at-
tempted, since anumberofchemicalsfoundtobetoxic
in saline were later shown to be inhibitory in serum.
FCS was found to protect the cell from toxicity at
concentrations of agent that inhibited attachment.
Compounds that are neither toxic nor inhibitory at
their solubility limit are reassayed at longer incuba-
tion intervals with the test compound (1-2 hr). EachJ. J. WELSH
datapoint is obtained intriplicate. Counts ofadherent
cells on the three disks are averaged and the number
of counts adherent to bovine serum albumin-coated
disks is subtracted as the control. Results are ex-
pressed as a percentage of attachment by untreated
cells to concanavalin A-coated disks (1,3,4). Another
measure used to assess an agent's effect is the con-
centration required in order to inhibit attachment by
50% (ID50).
Critical Review
Attempts have been made to validate this system
with over 100chemicals intwo basic categories, drugs
and pesticides. The lowest effective dose reported for
ateratogen was used to estimate teratogenic potency;
in considering nonteratogens, the highest reported
nonteratogenic dose was used. Inhibitory agents in-
cludedanti-inflammatorydrugs, sedatives, estrogens,
antibiotics, organophosphates, chlorophenols, chlori-
nated hydrocarbons, and chlorinated cyclodienes.
Braun and associates (3) observed 14 false negatives
on testing 74 chemicals that caused terata in vivo and
seven false positives on testing 28 compounds shown
not to be teratogenic in vivo. Several classes ofcom-
pounds, such as DNA damaging agents; inhibitors of
macromolecularsynthesis; andspecificcell-surfacere-
ceptors such as dexamethasone, hydrocortisone, iso-
proterenol, and vasopressin, cannot be characterized
by this system. As a result, complementary tests
would be essential for a teratogenicity screening sys-
tem. Braun and Horowicz (2) have suggested that
most of the false negatives generated by the attach-
ment assay inhibit mesenchymal cell growth. There-
fore, the palatal mesenchymal cell growth assay de-
velopedbyPrattetal. (5) couldbeusedincombination
with the cell attachment assay to predict teratogenic
potential.
Since the in vitro test system cannot mimic mater-
nal influences, the possibility has been discussed of
combining the use of serum, urine, or amniotic fluid
with test substances to more closely approximate the
natural state. The effects of teratogens have been
found to be dose-dependent within the assay system,
although in some cases the concentrations required to
inhibit cell attachment were substantially higherthan
those required to cause an embryonic malformation
in vivo.
The attachment inhibition assay is a relatively sim-
ple and very rapid test, taking less than 1 hr to com-
plete. Major equipment requirements include a liquid
scintillation counterandanincubator. Disposablesup-
plies such as concanavalin A, commercially available
medium, 3H-thymidine, pipets, and plastic bags for
the disks represent a cost ofapproximately $20 to $50
per compound tested. One full-time technician could
perform the assay, and since the test takes only 1 hr
to perform, contamination problems often associated
with longer term tissue culture work are eliminated.
The assay system is now being validated by Micro-
biological Associates (Bethesda, MD).
Inhibition of Intercellular
Communication in V79 Chinese
Hamster Cells and Human
Embryonal Palate Mesenchyme
(HEPM) Cells
Introduction
The normal development of embryonic tissues and
organs is thought to be partly dependent upon inter-
cellular communications. Wilson (6) suggested that one
of the mechanisms operating in teratogenesis was the
alteration ofcell membrane properties, leadingto afail-
ureincell-cell interactions. Interference with anyofthe
molecular structures involved in this type of commu-
nication, such as receptors, effectors, gap junctions,
proteins, or microtubules, could conceivably affect the
development of an embryo. A considerable amount of
work has been done on the inhibition ofcell-to-cell com-
munications by tumor promoters. Trosko et al. (7) have
postulated that the disruption of communication could
be responsible for both tumor promotion and terato-
genesis.
Yotti and associates (8) have developed a system
based on the phenomenon of metabolic cooperation,
which is a form ofcell-cell communication characterized
by the exchange of molecules between cells through
permeable gapjunctions formed at the sites ofcell con-
tact (9).
Methodology
The cells used in this assay are wild-type Chinese
hamster V79 cells, generated from the lung ofa normal
animal, that are sensitive to 6-thioguanine (6-TGs) and
X-ray-induced mutant cells that are resistant to 6-thio-
guanine (6-TGr). Cells are maintained in modified Ea-
gle's medium supplemented with a 50% increase in con-
centration ofvitamins, a 100% increase in nonessential
aminoacids, anda50%increaseinessentialaminoacids.
The medium also contains 1 mM sodium pyruvate and
5% FCS. The cells are grown in petri dishes and main-
tained at 37°C in a water-saturated atmosphere of 5%
CO2 in air (10). The assay involves co-culturing a num-
ber of mutant V79 cells lacking the enzyme hypoxan-
thine-guanine phosphoribosyltransferase (HGPRT)
with wild-type cells that possess the enzyme. The en-
zyme-deficient cells (HGPRT-) cannot metabolize 6-TG
and will replicate in tissue culture when cultured alone.
The wild-type population of cells has the HGPRT en-
zyme (HGPRT+) and will metabolize 6-TG to a toxic
substance that kills the cells. When HGPRT- (6-TGr)
cells are co-cultured with HGPRT+ (6-TGs) cells, the
toxic metabolite is transferred from the 6-TGs to the 6-
TGrcells and kills some or all ofthe HGPRT- mutants.
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The number of cells killed depends upon the density of
6-TGs cells, since there must be cell-cell contact viagap
junctions for the transfer to take place. Therefore, if
addition ofatestchemicaltothemediumcausesabreak-
down in cell attachment, the cultures will continue to
grow. If there is no inhibition of cell attachment, the
population of HGPRT- cells will decrease because of
the transfer ofthe toxic metabolite from the HGPRT-
cells to the HGPRT+ cells.
A negative control for the assay is prepared in the
absence of the test compound by co-culturing 400,000
to 500,000 6-TGs cells with 100 6-TGr cells in the pres-
ence of 10 jig of6-TG/mL ofculture medium. The non-
cytotoxic range must be est-ablished for each compound
tested before the assay can be performed.
According to the procedure described by Welsch and
Stedman (10), culture dishes (10 plates/concentration)
are seeded with the two cell types. Four hours later,
the test agent and 6-TG are added. After 72 hr, the
culture medium is replaced with fresh medium contain-
ing only 6-TG. Cultures are terminated after the third
or fourth day. The cells are washed with saline, fixed
with 95% ethanol, stained with crystal violet, and the
number ofcell colonies is recorded. The endpoint ofthe
assay is the ability of a compound to block metabolic
cooperation, measured by its capacity to increase the
number ofcell colonies recovered after 7 or 8 days over
the number of colonies found in the negative control
plates. The results ofthe assay are considered positive
only if the concentration resulting in the rescue of 6-
TGr cells is not cytotoxic. To account for spontaneous
mutations or mutations caused by the test substance
making the cells resistant to 6-TG, 6-TGs cells are cul-
tured in control medium or in medium containing the
highest concentration ofthe test agent used.
Critical Review
Trosko and co-workers (7) found that a variety of
chemicals have the ability to increase the recovery of
mutant 6-TGr cells when co-cultured with wild-type 6-
TGs cells. Positive responses in the assay included sev-
eral chemicals known or suspected to be structural or
behavioral teratogens (phenobarbital, 12-o-tetradeca-
noyl-phorbol-13-acetate (TPA), polybrominated biphen-
yls, polychlorinated biphenyls, mirex, Kepone, Dilan-
tin, and Valium). Thalidomide was not positive in this
system. Welsch and Stedman (10) noted that of six
chemicals known to be teratogenic in vivo (TAP,
2,4,5,2',4',5'-hexabromobiphenyl, diphenylhydantoin,
warfarin, ethylene glycol monomethyl ether, and eth-
ylene glycol monoethyl ether) all inhibited metabolic
cooperation in a dose-related manner at concentrations
which were similar to calculated in vivo dosages. Two
chemicals not known to have teratogenic potential in
vivo (saccharin and L-ascorbic acid) had no effect on
metabolic cooperation.
The assay at this time does not have a metabolic ac-
tivation system. Biochemical parameters can be meas-
ured, and results are reproducible. Most chemicals that
are water or solvent soluble may be tested in this sys-
tem. Required equipment includes a laminar flow hood,
water-jacketed CO2 incubator, and routine tissue cul-
ture supplies. One technician with experience in tissue
culture and sterile technique can operate the system.
The major limitation inherent in this system, as in
many other in vitro teratology assays, is that the test
looks at only one possible mechanism of action and
therefore cannot be considered a broad prescreen for
potential teratogens.
In an attempt to make this system more relevant,
Welsch et al. (11) have recently used HEPM cells to
studyintercellularcommunication. Thetransferof[3H]-
uridine between labeled and unlabeled HEPM cells is
used as a measure of cell-cell communication. In this
system, HEPM donor cells are placed onto coverslips
which are placed into multiwell tissue culture plates.
Thecellsareallowedtoattachandthenarepulselabeled
with [3H]-uridine for 3 hr. The cells are then cocultured
with unlabeled cells for 3 hr with or without the test
chemical to allow transfer of [3H]-uridine nucleotides
and incorporation into RNA. Cultures are washed and
fixed with formalin at 4°C. The cells are then treated
with warm (37°C) 5% trichloroacetic acid (TCA) twice
for5-min periods and finallyrinsed with distilled water.
The coverslips are then dried, attached to slides, and
processed for autoradiography. Donor cells are identi-
fied by the high density of silver grains over the cells.
Quantitative autoradiographyisperformedusinganAr-
tek 800 automatic grain counter. Radioactivity is de-
tectable in recipient cells which are in direct contact
with donor cells and in recipients making indirect con-
tactwith donors viaotherrecipients. Recipientcells not
making contact with donor cells do nothave counts that
exceed background.
Quantitative morphometric analysis has shown that
the amount ofintercellular communication is dependent
onthenumberofgapjunctions present. Onlytwo chem-
icals have been tested usingthis system. The teratogen
TPA inhibited transfer of [3H]-uridine from donor to
recipient cells but its structural analogue, 4ao-phorbol-
12,13-didecanoate, did not.
Cultured Mesenchymal Cells from
the Human Embryonic Palate
Introduction
A considerable amount ofwork has been done on de-
velopment of the secondary palate in mammals. It has
been established that rodent and human secondary pal-
ates develop quite similarly, even though human palate
development occurs at an earlier time in gestation. The
cellulareventsoccurringduringdevelopment ofthepal-
ate, such as growth, adhesion, death, and epithelial-
mesenchymal interactions, and the sensitivity ofpalate
cells to a variety ofteratogens have made this process
ofinterest to teratologists as a possible screen for ter-
atogens (5).
Palates have been used in organ culture for some
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time. Recently, a new technique has been made avail-
able that eliminates costly histologic preparations.
Yoneda and Pratt (12), in collaboration with the Amer-
ican Type Culture Collection, have established the
HEPM cell line. These mesenchymal cells originated
from aday 55 human abortus atthe time ofpalatal shelf
elevation and before epithelial contact. This cellline has
beenused byPratt andWillis (13)inateratogen screen-
ing assay which evaluates growth inhibition in HEPM
cells.
Methodology
Cells forthe assay are maintained in Dulbecco's mod-
ified Eagle's minimum essential medium (DMEM),
which contains 20% FCS and 10% dimethyl sulfoxide
(DMSO). HEPM cells are plated in35-mmFalcontissue
culture dishes at a density of4 to 5 x 104 cells per dish
in 2 mL DMEM containing glutamine, penicillin G,
streptomycin sulfate, and 10% FCS. Cultures are in-
cubated in humidified air containing 7% CO2 for 24 hr,
at which time the medium is replaced with or without
the test compound. The HEPM cells are then main-
tainedinculture foranadditional 72hr. Testcompounds
are dissolved in medium, water, ethanol, or DMSO. A
range-finding study is first performed to determine the
concentrationwhichinhibitscellgrowthshortoftoxicity
andthe concentration whichinhibits cellgrowthby only
10 to 15%. The IC50 (concentration that inhibits cell
growth by 50%) is determined using the mean from
threetofourdishes. Theexperimentisterminated after
96 hr, and cells are washed in calcium/magnesium-free
phosphate-buffered saline and are detached in 0.05%
trypsin/0.02% EDTA. Cell numbers are determined us-
ing a Coulter Counter, and the net growth is then cal-
culated. Percentages are plotted against test chemical
concentrations, and an IC50 for growth inhibition is in-
terpolated. Since nonspecific growth inhibition does oc-
cur at high concentrations, 1 mM has been set as the
concentration below which specific teratogenic inhibi-
tion of growth occurs.
Critical Review
The mesenchymal cell assay can reflect dose-depen-
dent responses, such as the growth inhibition observed
with the glucocorticoid dexamethasone (12). A micro-
somal, S-9, or whole cell metabolizing system can be
incorporated intotheHEPMcellcultureseitherdirectly
or in dialysis bags (14).
Evaluation ofthe HEPM system by Pratt and Willis
(13) focused on the list of chemicals and drugs tested
by Braun and co-workers in the Braun mouse ovarian
tumor cell-attachment assy (MOT). A total of 55 chem-
icals were tested. Ofthe 35 teratogens tested, 23 were
inhibitory, and 12 ofthe nonteratogens were not inhib-
itory. When the results of the HEPM assay and the
MOT assay are combined, they appear to be very com-
plementary, yielding an overall predictability of 90%,
with a false negative rate of3%. The effective overlap-
ping ofthese two screens demonstrates the advantages
of combining several complementary in vitro tests to
decreasethechancesthatanagentthatisteratologically
active in vivo will not be detected in a single screening
system. The assay is presently being validated by the
National Toxicology Program.
To perform the test, a laboratory must be equipped
with a laminar flow hood, one or two tissue culture
incubators, a phase contrast microscope, electronic cell
counter, medium, and common glassware. The cost per
HEPM assay is approximately $200 percompound. One
or two technicians with experience in tissue culture
work would be required to perform the assay. Pratt et
al. (5) have indicated that HEPM cells are quite similar
toinvivopalatalmesenchyme cells, andbecauseoftheir
human origin could be relevant as a screen for terato-
gens.
Porcine Granulosa Cell Culture
Introduction
Haneyetal. (15)havedeveloped asystemthatutilizes
ovarian granulosa cells to screen chemicals forpotential
reproductive toxicity. Granulosa cells, located within
the follicle and surrounding the ovum, produce the hor-
mone progesterone, which can be quantitated using ra-
dioimmunoassay (RIA) techniques.
Methodology
Porcine ovaries containing highly differentiated pre-
ovulatory follicles are collected under sterile conditions
andplacedinbuffered salinecontainingpenicillin, strep-
tomycin, mycostatin, and fungizone. Granulosa cells are
obtained by Haney's procedure (16) of bisecting each
follicle using sterile technique, removingthe follicle lin-
ing from its base, and suspending it in a mixture of
Ham's F-12 and DMEM containing penicillin and strep-
tomycin. Care must be taken to excise comparable size
follicles (6-9 mm), since the amount of hormone pro-
duced is directly related to the follicle diameter. The
follicle linings are agitated and abraded between aglass
rod and the wall of a plastic test tube, thereby sus-
pending the granulosa cells in the culture medium. De-
bris from the follicle walls are removed by filtration
through a nylon mesh filter. The cell suspension is then
centrifuged and resuspended, and cell viability is esti-
mated by vital staining with trypan blue using a hem-
ocytometer. Basal progesterone production levels are
determined for the population ofcells, after which they
are maintained for 24 hr at 37°C in a humidified atmos-
phere of5%CO2inair. Atthe endofthiscultureperiod,
the cultures are aspirated and frozen at - 196°C until
use. Haney et al. (15) observed that the viability ofthe
cells decreased only slightly in culture after cryopres-
ervation. Aliquots of cells are thawed as needed. The
cells are washed twice, resuspended, and checked for
cellviability. TheremainingcellsaredilutedwithHam's
F-12 and DMEM containing 5% FCS and insulin.
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The assay consists of four replicates for each group
in multiwell culture plates, with treatment groups con-
taining a vehicle (ethanol) and the test substance in
concentrations from 10-8 to 10-5 M. Control cultures
are treated with ethanol alone. Progesterone concen-
trations within the cells are determined by RIA (17).
Estradiol has been used by Haney et al. (15) as a ref-
erence treatment to verify the responsiveness of the
system, as its suppression of progesterone production
in granulosa cells (up to 75%) is well documented (16).
Additional biochemical parameters which could be
tested in the future include response to luteinizing hor-
mone/human chorionic gonadotropin, aromatase activ-
ity, or hormone receptor kinetics.
Critical Review
Since this assay is relatively new, few chemicals have
been tested, and therefore, validation is still necessary.
Water or solvent soluble chemicals maybe tested in this
system. Since reproductive toxicants may act by a va-
riety of mechanisms other than cytotoxicity, Haney et
al. (15) ran cycloheximide as an example ofan inhibitor
ofprotein synthesis. Results showed a decrease in pro-
gesterone production by 40% as compared to the con-
trol. Two isomers of DDT also tested positively in the
assay. The insecticides malathion, parathion, and diel-
drin, and the fungicide hexachlorobenzene all gave neg-
ative responses. However, due to the specificity ofthe
test, a negative response by a chemical in the assay
does not absolutely preclude the presence ofreproduc-
tive toxicity. Although not readily available, human
granulosa cells may be obtained as surgical specimens
and used to confirm results with porcine cells.
Results from this test are reproducible and are ca-
pable of showing a dose-related response. The mecha-
nism of action of the chemicals tested to date has not
been established, and there is no indication in the lit-
erature that a metabolic activation system has been
developed for the assay. The fact that the techniques
involved in this procedure require onlymodest amounts
of laboratory equipment and that materials can be ob-
tained inexpensively through slaughterhouses makes
the assay economically feasible. Technicians are re-
quired to have basic skills in cell culture and steroid
RIA techniques.
Differentiating Embryonic Neural
Crest Cells in Culture
Introduction
Embryonic neural crest cells have been used in cul-
ture (18,19) to test teratogenic and nonteratogenic com-
pounds. These ectodermal cells have been shown to dif-
ferentiate into autonomic neurons, glia, Schwann cells,
and pigment cells. Cranial neural crest cells also differ-
entiate into cartilage, bone, and connective tissue.
Greenberg (18,19) found that cranial neural crest cells
from 1.5-day-old chick embryos are multipotential and
differentiate within 6 days to form pigment cells when
cultured in FCS or neuronlike cells in horse serum. The
cultured cells also synthesize melanin and an extracel-
lular matrix containing collagen and glycosaminogly-
cans. During differentiation these cells are thought to
respond to teratogens that alter cell-substrate inter-
actions, mitosis, hormonal inductive factors, synthesis
ofgene products, and the elaboration ofan extracellular
matrix.
Methodology
According to Greenberg (18,19), primary cultures of
neural crest cells are established by cutting windows
into the eggs ofWhite Leghorn chicks to find embryos
whose cranial folds are in the process of fusing (stage
9). The vitelline membrane is peeled away, and the
neural tube is removed and placed in a plastic Petri dish
with Eagle's MEM containing2% chickembryo extract,
5% horse serum, and antibiotics. Over a 2-day period,
the neural tubes will attach to the dish, and cells of
neural crest origin will migrate away from the neural
tubes on the surface of the culture dish. The neural
tubes are removed at the end of the 2 days, and the
remaining monolayer ofneural crest cells is suspended
and distributed to 35-mm culture dishes. Compounds to
be tested are added to the cells in culture 1 day later.
Cultures are examined daily for approximately 1 week
by phase contrast microscopy to assess growth and dif-
ferentiation. Each assay is run twice with four dose
levels and a control. Any compound causing cell de-
tachment, a lower cell density, changes in cell shape,
orlackofdifferentiationcomparedtountreated controls
is considered to have a positive effect on the culture.
The minimum effective concentration that could induce
one ofthese effects is considered to be the end point of
the assay. It is also possible to assay the cells biochem-
ically on day 7 for choline acetyltransferase activity or
melanin synthesis.
Critical Review
When metabolic activation has been necessary, the
test compound has been incubated with the post-mito-
chondrial supernatant fraction (S-9) oflivermicrosomes
of phenobarbital-treated rats plus an NADPH-gener-
ating system. Since the S-9 mixture was found to be
toxic when added directly to the cell cultures, Green-
berg (19) combined the fraction with the test compound
in a dialysis bag and placed it in the culture medium.
Over a 4 hr period, the compound and its metabolites
diffused through the culture medium.
The effects ofchemicals tested within this system are
dose-dependent. Nine of eleven compounds previously
shown tobe teratogenic invivo induced detectablemor-
phologic alterations in the neural crest cells. Phosphor-
amide mustard, norchlorocyclizine, diphenylhydantoin,
and P-aminopropionitrile elicited positive responses in
the assay at concentrations similar to maternal blood
levels associated with malformations in vivo. In con-
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trast, 5-bromo-2'-deoxyuridine and retinoic acid were
active at lower concentrations in culture than in vivo.
It has been postulated that maternal protective pro-
cesses are at work in vivo to decrease exposure to the
embryo. Thalidomide and acetylsalicylic acid had no ef-
fect on neural crest cultures.
Proponents ofthis system feel that neural crest cells
are a relevant model for the whole animal because the
cells proliferate and form cellular associations, adhere
to the substrate, produce extracellular matrix, and dif-
ferentiate. However, cultures such as these do not pos-
sess the cell interactions that can be found in the more
complex systems of organs or whole embryo culture
where many cell types are found to interact. Homotypic
cultures such as the one described here can provide a
quantitative and qualitative assessment of test com-
pounds more easily and faster than complex systems,
andthebiochemical determinations ofmelaninsynthesis
and choline acetyltransferase activity are reproducible.
One of the major disadvantages in this type of system
is that biochemical assays require larger numbers of
cellsthanmorphological determinations. Greenberg(19)
has stated that typically 6 to 9 dozen eggs will produce
enough neural crest cells from dissected embryos to
perform duplicate tests using morphological end points
on six concentrations oftwocompounds. Therefore, ter-
atology screens which use primary cell cultures such as
this system are limited by the number of cells that can
be generated.
The assay is labor-intensive because of the difficulty
ofthe dissections. However, one skilled technician with
tissue culture experience and training in the dissection
technique couldperformthe assay. Required laboratory
equipment includes a laminar flow hood, an incubator
for the cell cultures, an egg incubator for the chick em-
bryos, a phase contrast microscope, and disposable tis-
sue culture supplies.
Limb Bud Mesenchyme Cell Culture
Introduction
Kochhar (20) and Hascall et al. (21) have shown that
cell to extracellular matrix interactions are essential for
normal embryonic development. A system that has the
ability to detect disruption in these relationships can
provide relevant data about the effect ofteratogens on
morphogenesis. The extensive use oflimb bud (LB) cell
culture in the investigation ofthe processes involved in
chondrogenesis has led to thedevelopment ofan invitro
screen for teratogens. Wilk et al. (14) have described
LB mesenchyme cells that grow and differentiate into
chondrocytes in culture and synthesize an easily quan-
tifiable extracellular matrix product, namely, sulfated
proteoglycan. The amount ofproteoglycanproduced de-
pends on the extent ofgrowth and differentiation over
a 6-day culture period. Agents that interfere with
growth or differentiation reduce the amount of proteo-
glycan present in the chondrocytes.
Methodology
Accordingto Hassell etal. (22,23) andWilketal. (14),
LBs are isolated from 10- to 12-day-old mouse embryos
or day 4 chick embryos, and then are dissociated by
trypsinization, suspended in MEM supplemented with
fetal bovine solution (FBS), vortexed, and filtered to
remove debris. The resulting single-cell suspension is
usedtoseedindividual culturesin24-wellCostardishes,
which are placed in a humidified CO2 incubator at 37°C
for 1 to 3 hr to allow cell attachment. Once the cells
attach, wells are flooded with either CMRL culture me-
dium containing 10% FBS (mouse cultures) or Eagle's
MEM with 10% FBS (chick cultures). On the following
day, the test compound dissolved in water, ethanol,
DMSO, or control solvents are added to the cells via
the medium, which is changed on days 1, 3, and 5. The
total treatment time is designed to cover the critical
period of LB cell differentiation.
The cultures are monitored daily by phase contrast
microscopy to follow cell differentiation. The accumu-
lation of sulfated proteoglycans is determined on day 6
after the cells are stained with alcian blue (23). Un-
bound dye is removed from the cells by several acid
rinses. After the bound dye is extracted from the cells,
itmaybe quantitated spectrophotometrically at 600nm.
Normal cells in this system show a progressive increase
in staining, which plateaus between days 5 and 6. A
positive effect by a teratogen in this systemwould elicit
a decrease in proteoglycan production. Cellular and ex-
tracellular macromolecular synthesis may be quanti-
tated by the incorporation of radiolabeled compounds
and scintillation counting. Additional effects that have
been observed include cell detachment from the sub-
stratum, decreased cell proliferation, cell morphology
change, and failure to differentiate.
Duringthe culture period, cellnumberincreasesfour-
to sixfold, and gene products change. Compounds that
act by inhibiting cell proliferation test positively in this
system, since a reduction in cell number would mean a
corresponding decrease in extracellular matrix. Cell
products change from type I to type II collagen and
from mesenchyme proteoglycan to cartilage proteogly-
can, and the synthesis offibronectin is terminated. Any
compound that interferes with these processes could be
considered a potential teratogen. The mechanism of
chondrogenesis inhibition can be determined by
radioisotope incorporation or chemical measurement.
Tests are conducted in triplicate; a range of doses is
used for each compound. An equivalent amount of
vehicle is used in the control cultures without the test
agent. The amount ofAlcian blue staining at each dose
is expressed as a percent of the control cultures. The
teratogenic potential of a compound is quantitated by
findingthe concentration required to reduce stainingby
50% (TP50) from a dose-response curve that may be
correlated to proteoglycan production.
Critical Review
Some chemicals found to be inhibitors of chondroge-
nesis in this assay are cytosine arabinoside, actinomycin
230CELLS IN CULTURE
D, vitamin A, and hexachlorophene. Proven and sus-
pected teratogens such as 3-aminopropionitrile and di-
phenylhydantoin have also been tested with positive
results. Concentrations ofthe chemicals tested thus far
have been in the range of blood levels known to cause
malformations in vivo. Thalidomide tested negatively
in the assay without the use of an activation system.
Nonteratogenic chemicals had no effect on growth and
differentiation.
This system may be used in conjunction with one of
several metabolic activating systems. Serum from
treated animals or humans may be added to the culture
medium to test for teratogenic metabolites produced in
vivo, or a combination of an S-9 fraction and NADPH-
generating system can be used to activate compounds.
In addition, Hassell and co-workers (23) are attempting
to coculture primate liver cells with the LB cells.
Theassayrequires oneortwotechnicianswithknowl-
edge in basic animal care, surgery, liquid scintillation
counting, and tissue culture techniques. Equipment re-
quirements include a laminar flow unit, incubators, liq-
uid scintillation counter, microtiter dishes, and time-
pregnant mice.
Litton Bionetics currently offers the assay as a broad
pre-screen for teratogens. The procedure described by
Guntakatta et al. (24) is a modified method which uses
radiochemicals for the assessment of chemical effects
on sulfated proteoglycan and DNA synthesis in mouse
LB cells. In this method, hindlimbs are dissected from
10 to 15 dams and pooled in 4°C PBS. The LBs are
dissociated with trypsin-EDTA, and the resulting cell
suspension is filtered, washed, and resuspended in
CRML 1066 culture medium containing L-glutamine,
penicillin, streptomycin, and heat-inactivated FBS. In
routine cultures, 10-1iL aliquots of the cell suspension
are seeded into 16-mm wells of 24-well culture dishes.
The cells are allowed to attach over a 2-hr period and
then are fed with 1.0 mL CMRL medium and incubated
at 37°C in 95% air and 5% CO2 in a humidified atmos-
phere.
The test chemicals are added to each spot 24 hr later
and control cultures are re-fed with culture medium.
After 72 hr of treatment, the medium is removed and
the cultures are re-fed with reduced sulfate labeling
medium containing [3H]-thymidine, 35S04-2, and test
chemical, and incubation is continued for another 24 hr.
Spot cultures are washed with phosphate-buffered sa-
line and macromolecules precipitated with 10% TCA.
After 18 to 24 hr at 4°C, the precipitates are washed
with cold TCA and then solubilized in 1% sodium do-
decyl sulfate (SDS) at 37°C. After 4 to 8 hr, the radi-
oprecursors in the SDS-solubilized material are esti-
mated in a liquid scintillation counter. The accumulated
cartilage proteoglycans are estimated by Alcian blue
staining. Cultures are stained with 0.5% Alcian blue in
3% glacial acetic acid. After 2 hr, the cultures are
treated with 3% acetic acid for 10 min and then 2 min
with glacial acetic acid. Bound stain is eluted for 16 to
24 hr with 8 M guanidine hydrochloride at 4 to 6°C. The
absorption ofAlcian blue dye in the spot is then deter-
mined at 600 nm. The inhibition ofeither proteoglyean
synthesis or DNA synthesis was determined for 19 of
22 known mouse teratogens by Guntakatta et al. (24)
using double-labeling experiments. Five nonteratogens
tested negatively in this assay. The overall accuracy of
the systemwas 89% with afalse negative rate of14.8%.
No false positives were observed. Development of an
exogenous activating system for the mouse embryo LB
cell culture system is currently under way.
Differentiation of Rat Embryo
Midbrain and Limb Bud Cells in
Culture
Introduction
Flint recently developed a short-term assay for ter-
atogens using differentiating rat embryo midbrain
(CNS) and limb bud (LB) cells in culture. Two methods
usingbothinuterochemicalexposureandinvitrochem-
ical exposure are described in the literature (25,26).
Most of the in vitro teratology screening systems de-
veloped to date require the addition of the test sub-
stance directly to the culture medium, with or without
the use of a metabolic activating system. Occasionally,
serum from humans or amniotic fluid from pregnant
animals exposed to teratogens has been added to the
medium of cultured cells. In early work by Flint et al.
(25), rat embryos were exposed to a variety of terato-
gens and nonteratogens in utero, and embryonic LB
cells and midbrain cells were subsequently cultured.
This approach allows for maternal metabolism of the
test agent and gives the yolk sac and placenta an op-
portunity to exert an influence on the compound. The
cells are cultured for 5 days, permitting cell differen-
tiation. During this time, cells in LB cultures group
together in small foci of chondrocytes and secrete sul-
fated proteoglycans. CNS cells differentiate into neu-
rons, which are organized into foci surrounded by fi-
broblasts. Thegrowth ofthe cellsisdetermined bytotal
protein and differentiation by morphometric assay and
the incorporation of radiolabeled substrate. In a more
recent method, the test compound is added directly to
the culture medium, which simplifies the procedure and
conserves animals.
Methodology
In Flint's in vivo exposure procedure (25), the test
compound or vehicle control is administered intraperi-
toneally to pregnant rats on day 12 ofgestation. Doses
normally range approximately midway between the
highest and lowest active dose forteratogens and at the
maximum nontoxic acute dose for nonteratogens. The
animals are sacrificed 16 hr after dosing, and embryos
(34-36 somites) are removed aseptically to a medium
containing horse serum and Earle's Balanced Salt So-
lution at 37°C. LB cells are prepared by the methods
describedbyAhrens and co-workers (27), andCNScells
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are prepared from the mesencephalon by techniques
developed by Flint (28). Occasionally, embryonic tissue
from a pair ofanimals will have to be pooled to provide
enough tissue to complete an experiment. Flint et al.
(25) havejustified this procedure by demonstratingthat
there is little variation between animals for the param-
eters noted. Briefly, tissues are dissociated by trypsin-
ization and resuspended in Ham's F12 culture medium
containing FCS, L-glutamine, penicillin, and strepto-
mycin. Aliquots of the two cell types are delivered to
plastic dishes for 2 hr at 37°C to allow for cell attach-
ment. Culture medium (2 mL) is then added to each
dish, and cultures are incubated for 5 days at 37°C in
an atmosphere of 5% CO2 in air and 100% humidity.
Within each dish, a small circular island ofcells forms.
One LB cellislandandtwo CNS cellislands arecultured
in each dish for protein content and isotope incorpora-
tion. Five CNS and three LB cell islands are cultured
in each dish for determinations of cell differentiation.
Five replicate dishes are prepared for each assay. LB
cultures are fixed in 10% formaldehyde, and proteogly-
cans are stainedwithalcianblue. CNSculturesarefixed
in 10% formaldehyde and stained with hematoxylin.
Protein content is estimated by the method of Lowry
et al. (29). Differentiation is measured by the number
ofstainable focipresent and3H--y-aminobutyric acid (H-
GABA) incorporation in CNS cells and [35S]-sulfate in-
corporation in LB cells. H-GABA and [35S]-sulfate are
determined by exposing CNS cells to H-GABA for 1 hr
on day 5 and LB cells to [35S]-sulfate for the entire day
5 culture period. At the end of the exposure period,
radioactivity is determined with a liquid scintillation
counter. Differentiated cells are analyzed morphometr-
ically with adissecting microscope attached to an Artek
980 colony counter that automatically counts areas of
high contrast (darkly staining foci of cells).
In the wholly in vitro procedure, embryos are re-
moved and dissected, and the cells prepared as de-
scribed inthefirstmethod. AnS-9ratlivermetabolizing
system may be constituted according to the procedure
described by Ames et al. (30). The prepared dishes of
cells are incubated at 37°C in 5% CO2 in air and 100%
humidity for 2 hr, after which the test compound with
or without the S-9 mix is added in a final volume of 2-
mL culture medium. Cultures are exposed to the com-
pound at concentrations of0.1, 1, 10, 100, 200, and 500
,ug/mL. Ifused, the S-9 mix is removed after 2 hr due
to cytotoxicity and replaced with fresh culture medium.
Concurrent control culturesreceive theappropriate vol-
ume of solvent only. Cells once again develop distinct
micromass islands during the 5 days in culture. At the
end ofthisperiod, CNScells arefixed with 10%aqueous
formaldehyde and LB cells with aqueous cetylpyri-
dinum chloride/10% formaldehyde. CNS cultures are
stained with Delafield's hematoxylin and LB cultures
with alcian blue. The numberofstainedfociismeasured
automatically by an Artek 980 colony counter. The con-
centration at which each compound inhibits the for-
mation ofdifferentiated foci by 50% ofthe control value
(IC50) is determined. Inhibition of differentiation in
either CNS or LB culture is used as the criterion for
potential teratogenicity.
Critical Review
Nonteratogens had no effect on cultured differen-
tiating rat embryo cells in the in vivo exposure assay.
Teratogensinhibited LB and CNSculturesby44to70%
ofthecontrols. Azathioprene, dexamethasone, 2,4-dich-
lorophenoxyacetic acid, ergotamine tartrate, mitomycin
C, phenobarbitone, and methyl testosterone all tested
positively by inhibiting growth and differentiation. No
nonteratogen was found to inhibit culture development
bymorethan20%. Oftheteratogens, amaranth, EDTA,
griseofulvin, and thalidomide inhibited development by
less than 20%. However, by employing discriminant
analysis of the data, only nitrilotriacetic acid could be
identified as a false positive and amaranth as a false
negative. Overall sensitivity ofthe assay was 92% cor-
rect for teratogens and 94% correct for nonteratogens
in a total of 31 compounds.
In the in vivo exposure method, repeat experiments
using two known teratogens, aldrin and diphenylhy-
dantoin, showed that interexperimental variability was
low. The assay was able to differentiate between the
teratogenic activity of several pairs ofcompounds with
similarchemical structures. The sensitivity ofthe assay
was 93% forprediction ofteratogens, andthe specificity
was 89% for prediction ofnonteratogens in a total of46
compounds tested (27 teratogens, 19 nonteratogens). If
inhibition of differentiation of only one cell type was
considered, then the predictive value was lower (CNS
85%, LB 82%). False negative compounds were 2,4-
dichlorophenoxyacetic acid and thalidomide. The false
positive compounds were glutethimide and dimenhy-
drinate.
These assays are relatively short term (5 days for
culture development and 1 day for quantification), use
small numbers of rats, and exhibit dose-related re-
sponses. The in vivo assay excludes the possibility of
nonspecific cytotoxicity generated by direct addition of
test compounds to the culture medium. Both assays
appear to have the same predictive capabilities.
Required equipment for the assays include a liquid
scintillation counter, incubators, microscope, radioiso-
topes, and routine tissue culture supplies. The value of
both assays as a screen for teratogens will have to be
evaluated after additional chemicals are tested.
Drosophila Embryonic Cell Culture
Introduction
Bournias-Vardiabasis andTeplitz(31)havedeveloped
an in vitro teratology screen using Drosophila melan-
ogaster. The assay is based on a quantitative determi-
nationofmuscleandneurondifferentiationinembryonic
cell cultures. Early work by Seecof and Donady (32)
showed that primary cell cultures of Drosophila pro-
vided averyeffective systemforthestudyofembryonic
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stem cells that differentiate into neurons and muscle
cells. They noted in their studies that differentiation of
neuron and muscle in vitro was very similar to that in
vivo, with only a short time lag in the cultured system.
It is assumed that Drosophila embryo muscles and neu-
rons are derived from the same basic mechanisms that
operate in vertebrates and that the cells respond to
chemical insult in the same way as vertebrate cells.
Bournias-Vardiabasis and Teplitz (31) demonstrated
that Drosophila cells did, in fact, respond very similarly
to vertebrate cells when exposed to insulin and various
metabolic inhibitors.
Methodology
The basic procedure as described by Bournias-Var-
diabasis et al. (31,33) involves the mass collection of
Oregon R strain Drosophila eggs over a 2-hr period
using population cages. The eggs are sterilized at the
early gastrula stage, before any morphological or ul-
trastructural differentiation. Eggs are then homoge-
nized and centrifuged so that a pellet ofembryonic cells
is collected. The cells are plated in 35-mm culture
dishes, and Schneider's medium containing 18% heat-
inactivated FCS is added. Once the cells attach to the
bottom ofthe dish (15-20 min), the medium is replaced
with medium in which the test compound is dissolved.
Agents may be dissolved in either water, alcohol, or
DMSO. All solvents have been tested and allow normal
cell differentiation. The proper range ofconcentrations
to be tested is determined by feeding the compound to
the adult female Drosophila and determining the LD50.
The concentrations used in the assay would then be a
10- to 100-fold dilution ofthis dose. Controls are treated
in the same manner as experimental compounds. After
the test agent has been added, the cultures are placed
in 25°C incubators and are scored for cell and tissue
differentiation 24 hr later. During this period, several
types ofcells differentiate from their stem cells, as ob-
served by phase contrast microscopy. Neuroblasts di-
vide, forming daughter neurons, which in turn form
small ganglia; and myoblasts divide and become mon-
onucleated myocytes, which eventually become multi-
nucleated myotubes. The differentiated cultures are
rinsed in 0.1% trypsin in saline solution to remove cel-
lular debris, fixed in Zenker's solution, stained with
hematoxylin, and counterstained with Evans' blue. If
interference with normal differentiation occurred at an
early stage ofdevelopment, the number ofcells should
be reduced. Interference later in development could re-
sult in abnormal myotubes.
In addition to the number of ganglia and myotubes
present, axons, F cells, C cells, pulsations, and neu-
romuscular contacts may be counted. Biochemical pa-
rameters can also be measured, such as the production
of acetylcholinesterase or choline acetyltransferase.
However, to keep the assay simple, endpoints are usu-
ally limited to counts of myotubes and ganglia. The
speed of the assay can be increased by the use of an
image analyzer (Bausch and Lomb Omicon), which au-
tomatically scores the number ofmyotubes and ganglia,
thus decreasing the number of hours required to per-
form the test. Four dishes are scored for each chemical
tested, and the number of myotubes and ganglia are
averaged and computed as a percentage of the control
average. The assay provides dose-response relation-
ships for ganglia and myotube differentiation. Three or
more separate trials are run for each compound. To be
classified as a teratogen, an agent must have caused a
reduction in differentiation as evidenced by a 50% de-
crease in the number of neurons and/or muscle in
treated versus control groups. The assay takes 3 days
to complete.
Critical Review
There has been good correspondence between this
assay and other systems such as in vivo animal studies
and human epidemologic studies. In an attempt to val-
idate the assay, Bournias-Vardiabasis et al. (33) tested
over 100 commonly used industrial chemicals, drugs,
and food additives. Of the 45 agents testing positively
in the assay, only two false positives were found (p-
aminobenzoic acid and dimethylacetamide). Fifty-five
chemicals had no effect on embryonic differentiation,
and only four of those chemicals could be classified as
false negatives (pilocarpine, lead nitrate, ethyl alcohol,
and cylophosphamide). Among the chemicals testing
positively in the assay were acetylsalicylic acid, aden-
ine, amethopterin, atropine, urethane, mercuric chlo-
ride, and testosterone. Thalidomide interfered with
muscle and neuron differentiation without the use of a
microsomal activating system, in contrast to previously
published datawhichindicatedthatthalidomide's action
was dependent upon metabolic activation.
Teratogenicehemicalshavebeenactivatedinthissys-
tembyseveralmethods, includingtheuseofserumfrom
animals fed suspected teratogens, serum from patients
on chemotherapy (vincristine and nitrogen mustard),
and low concentrations of human urine, with positive
results. Methods are currently being developed for the
routine addition of an S-9 fraction or the microsomal
fraction (S-27) from Drosophila (34).
This is an inexpensive assay for which a full-time
technician could easily be trained. Tissue culture ex-
perience is not a prerequisite for performingthe assay.
Required equipment includes Drosophila population
cages, Drosophila food, tissue culture incubator, ho-
mogenizer, glassware, and media. Total start-up costs
are modest, excluding the cost of the image analyzer,
which is not a necessity. The use of a specialized port-
able incubator can expand the capability of the system
to testing a variety of gases. The assay must be con-
ducted in a roomthat is isolated frommammalian tissue
culture work because ofthe possibility ofyeast contam-
ination from the Drosophila food.
This assay, in addition to its use as a short-term
screen for potential teratogens, also has the potential
forinvestigations intothemechanisms ofteratogenesis.
Becauseofthevastamountofinformation onthegenetic
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characteristics ofDrosophila, this system lends itselfto
the study ofgenes that control embryonic and fetal de-
velopment. As with other cell culture assays, this sys-
tem could be used in conjunction with other comple-
mentary tests.
Buzin and Bournias-Vardiabasis (35) have recently
used two-dimensional gel electrophoresis to study pro-
tein synthesis in Drosophila embryonic cells treated
with drugs. Dose-response studies have shown a cor-
relation between the degree ofinhibition ofdifferentia-
tion and the level ofinduction ofthree specific proteins.
These proteins appear to be identical to three proteins
which had previously been induced by heat shock. Nine
teratogens have been tested individually in Drosophila
primary embryonic cells, and the three proteins (hsp
23, 22a, and 22b) were induced in each case. Three ter-
atogens and eight nonteratogens did not induce these
proteins. Buzin and Bournias-Vardiabasis have stated
that the chemical induction ofthese heat shock proteins
may reflect specific types ofstress which in themselves
may be teratogenic (35).
Differentiating Neuroblastoma Cells
Introduction
Murine neuroblastoma cells (clone NIE-115) have re-
cently been used by Mummery and co-workers (36) in
an assay that detects agents capable ofinterferingwith
growth and differentiation. Neuroblastoma cells are
precursors of sympathetic ganglia derived from malig-
nant tumors originating from neural crest cells (37).
Under appropriate conditions, the cells will undergo
terminal neuron differentiation. Some ofthe character-
istics exhibited bythese differentiating cells include ex-
tension ofneurites (processes longer than the diameter
of the cell body), production of enzymes, and the de-
velopment ofanelectrically excitable plasmamembrane
(38). While working with these cells, Schubert and as-
sociates (39) noticed that if serum was removed from
the cells duringculturing, the neuroblastomacells could
be induced to differentiate. Since neural tissue has been
known to influence several processes ofembryogenesis
such as limb development, and neuronal damage has
been implicated as a factor in teratogenesis, a screen
for teratogenicity utilizing differentiating neural tissue
could be of value.
Methodology
The procedure developed by Mummery et al. (36)
entails growing mouse NIE-115 neuroblastoma cells in
DMEM containing glucose and FCS. Subcultures of
stock cells are plated in 1.6-cm diameter wells in 1 mL
of DMEM containing 7.5% FCS. The cultures are in-
cubated at 37°C for 24 hr, at which time the medium is
changed, and the test substance, dissolved in water,
ethanol, or DMSO, is added to the wells at various con-
centrations. Both the medium and the test substance
arereplaced onday4. Cells growninmediumcontaining
serum grow exponentially as rounded cells and are con-
fluent by day 7. Control cultures at this time exhibit
low levels of spontaneous differentiation in the form of
neurite production. Any substance that induces the for-
mation of neurites in significantly greater quantities
thanthecontrolisconsideredtobepositiveintheassay.
Viable cells are identified by trypan blue exclusion and
are counted and expressed as a percentage ofthe con-
trol. Three parameters are measured in triplicate for
each test substance: (1) the minimumdosefor 100% cell
death; (2) maximum nontoxic dose that causes no de-
crease in cell number; and (3) if applicable, the mini-
mum dose resulting in an effect on differentiation (low-
est effective dose). The cell number at the end of the
test is also determined for the lowest effective dose for
each substance and expressed as a percentage of the
control.
Inhibition ofdifferentiation is also determined in the
assay by culturing cells in DMEM with FCS, but after
24 hr the medium is replaced without FCS. Test sub-
stances are added to the medium and replaced on day
4. Byday7, allcontrolcellshave differentiated, forming
a network ofthin neurites. Wells are photographed and
scored positive if neurite formation is inhibited.
Critical Review
Mummery et al. (36) tested 42 teratogens and found
that 32 induced morphological differentiation, including
mercaptopurine, urethane, and hydroxyurea. Three
known teratogens could not be categorized by the sys-
tem. Thalidomide was relatively insoluble, leading to
high concentrations ofthe solvent, and methylthiouracil
and phenytoin both induced differentiation at toxic
doses. Ofthe 19 nonteratogens tested, 14 gave negative
results. Cyclamic acid could not be categorized because
ofthe highconcentrations requiredtoproduce aneffect,
and the remaining four scored positively. Only 3 of 57
chemicals tested by Mummery et al. inhibited differ-
entiation (retinoic acid, insulin, and Hg2+). It was also
noted that the toxic dose for cells grown in the absence
ofFCSwasapproximatelyoneorderofmagnitudelower
than cells grown in the presence of FCS. Mummery et
al. (40) had previously shown that serum tended to re-
duce the potency of toxic chemicals in exponentially
growing neuroblastoma cells.
Overall, the assay system was capable of correctly
identifying 49 of 57 (86%) teratogenic and nonterato-
genic agents. Of the 39 teratogens, 4 were false nega-
tives, and of the 18 nonteratogens (22%), 4 were false
positives. The system has generated results similar to
Braun's tumor cell attachment assay (1,4), with some
improvement. Judging from the compounds tested, the
system appears to be sensitive to teratogens that alter
tissue development and inhibit growth processes. Met-
abolic activation was not employed in this assay, but
the option of preincubation of agents with liver micro-
somes (30) has been discussed as a possibility. The use
ofembryonic neuroblastoma cells in a test system such
as the one described could be of value in the study of
234CELLS IN CULTURE 235
the regulatory role of the plasma membrane in growth
and differentiation and in the mechanisms involved in
teratogenesis.
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